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Abstract. 
 
Two collagen receptors, integrins 
 
a
 
1
 
b
 
1 and 
 
a
 
2
 
b
 
1, can regulate distinct functions in cells. Ligation of 
 
a
 
1
 
b
 
1, unlike 
 
a
 
2
 
b
 
1, has been shown to result in recruit-
ment of Shc and activation of the Ras/ERK pathway. To 
identify the downstream signaling molecules activated 
by 
 
a
 
2
 
b
 
1 integrin, we have overexpressed wild-type 
 
a
 
2, 
or chimeric 
 
a
 
2 subunit with 
 
a
 
1 integrin cytoplasmic do-
main in human osteosarcoma cells (Saos-2) lacking en-
dogenous 
 
a
 
2
 
b
 
1. The chimeric 
 
a
 
2/
 
a
 
1 chain formed a 
functional heterodimer with 
 
b
 
1. In contrast to 
 
a
 
2/
 
a
 
1 
chimera, forced expression of 
 
a
 
2 integrin resulted in 
upregulation of 
 
a
 
1 (I) collagen gene transcription in re-
sponse to three-dimensional collagen, indicating that 
the cytoplasmic domain of 
 
a
 
2 integrin was required for 
signaling. Furthermore, signals mediated by 
 
a
 
2
 
b
 
1 inte-
grin speciﬁcally activated the p38
 
a
 
 isoform, and selec-
tive p38 inhibitors blocked upregulation of collagen 
gene transcription. Dominant negative mutants of 
Cdc42, MKK3, and MKK4 prevented 
 
a
 
2
 
b
 
1 integrin–
mediated activation of p38
 
a
 
. RhoA had also some
inhibitory effect, whereas dominant negative Rac was 
not effective. Our ﬁndings show the isoform-speciﬁc ac-
tivation of p38 by 
 
a
 
2
 
b
 
1 integrin ligation and identify 
Cdc42, MKK3, and MKK4 as possible downstream ef-
fectors. These observations reveal a novel signaling 
mechanism of 
 
a
 
2
 
b
 
1 integrin that is distinct from ones 
previously described for other integrins.
Key words: collagen • integrin • cytoplasmic domain 
• p38 MAPK
 
I
 
NTEGRIN
 
 type receptors bind extracellular matrix
 
(ECM)
 
1 
 
molecules and mediate cell adhesion, migra-
tion, and invasion during development, tissue repair,
tumor invasion, and metastasis. They also act in concert
with growth factor or cytokine receptors to regulate cell
proliferation, differentiation, and survival (Hynes, 1992;
Clark and Brugge, 1995). The relatively short cytoplas-
mic domains of the integrin 
 
a
 
 and 
 
b
 
 subunits do not have
any intrinsic enzymatic activity, but integrin signaling is
achieved by coupling signaling molecules, such as tyrosine
kinases, to the cytoplasmic and transmembrane domains
of the integrin subunits (Yamada and Miyamoto, 1995).
The 
 
b
 
 cytoplasmic domains share conserved regions,
whereas the 
 
a
 
 cytoplasmic domains have highly divergent
amino acid sequences (Laflamme et al., 1997). Integrins
activate signaling pathways that are either common to all
integrins or heterodimer specific (Giancotti, 1997). Early
integrin-triggered signaling events seem to be mediated by
the cytoplasmic domains of the 
 
b
 
 subunits. These include
the tyrosine phosphorylation of the focal adhesion kinase
(FAK) (Schaller et al., 1994) and recruitment of compo-
nents of the actin-based cytoskeleton, such as 
 
a
 
-actinin
and talin (Horwitz et al., 1986; Otey et al., 1990). In the
next step, a large number of proteins with enzymatic activ-
ity, like kinases and GTPases, are recruited to the sites of
adhesion. Activation of these signaling proteins is medi-
ated both by the 
 
b
 
 subunits and specifically by individual 
 
a
 
subunits (Howe et al., 1998).
The functions of 
 
a
 
 cytoplasmic domains of various inte-
grins are distinct. Cytoplasmic domains of 
 
a
 
5 and 
 
a
 
L are
not required for cell adhesion unlike those of 
 
a
 
2 and 
 
a
 
4.
In the context of cell adhesion and migration, some of the
 
a
 
 cytoplasmic domains seem to be interchangeable (Kass-
ner and Hemler, 1993), whereas signaling events specific
for each individual integrin heterodimer may be triggered
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by the 
 
a
 
 cytoplasmic domains (Z. Zhang et al., 1995; Sas-
try et al., 1996).
Four members of the integrin family are known to bind
collagens, namely 
 
a
 
1
 
b
 
1, 
 
a
 
2
 
b
 
1, 
 
a
 
3
 
b
 
1, and 
 
a
 
10
 
b
 
1 (Camper
et al., 1998). 
 
a
 
1
 
b
 
1 and 
 
a
 
2
 
b
 
1 are considered to be the
two major collagen binding integrins, whereas 
 
a
 
3
 
b
 
1 seems
to function as an assisting receptor (DiPersio et al.,
1995). The recently identified integrin 
 
a
 
10
 
b
 
1 is expressed
on chondrocytes, but little is known about its biology
(Camper et al., 1998). 
 
a
 
1
 
b
 
1 and 
 
a
 
2
 
b
 
1 are concomitantly
expressed by many cell types but they may regulate differ-
ent functions. Three-dimensional ECM culture systems
provide means to study cell–matrix interactions in a more
natural environment than the traditional monolayer cul-
ture (Grinnell, 1994). The studies with three-dimensional
collagenous matrices have shown that ligation of 
 
a
 
2
 
b
 
1
triggers MMP-1 expression (Langholz et al., 1995; Rii-
konen et al., 1995a) and induces collagen gel contraction
(Chan et al., 1992; Riikonen et al., 1995b). In fibroblasts,
contact to collagen also leads to the activation of protein
kinase (PK) C-
 
z
 
 and NF
 
k
 
B and that correlates with the
upregulation of 
 
a
 
2
 
b
 
1 integrin and MMP-1 gene expression
(Xu and Clark, 1997), suggesting that these phenomena
are mediated via 
 
a
 
2
 
b
 
1. On the other hand, 
 
a
 
1
 
b
 
1 integrin
mediates downregulation of collagen 
 
a
 
1(I) mRNA levels
both in vitro and in vivo (Langholz et al., 1995; Riikonen
et al., 1995; Gardner et al., 1999). A subset of integrins,
including 
 
a
 
1
 
b
 
1, have been shown to activate the mitogen-
activated protein kinase (MAPK) extracellular signal-
related kinase (ERK) via recruitment of Shc and activa-
tion of Ras (Wary et al., 1996; Mainiero et al., 1997; Pozzi
et al., 1998), suggesting that 
 
a
 
1
 
b
 
1 integrin is the collagen
receptor that regulates cell proliferation in collagenous
matrices. In contrast, 
 
a
 
2
 
b
 
1 appears to be unable to recruit
Shc and activate this specific signaling pathway.
We have previously observed that overexpression of
 
a
 
2
 
b
 
1 integrin prevents 
 
a
 
1
 
b
 
1-mediated downregulation of
collagen 
 
a
 
1(I) mRNA levels when cells are brought into
the contact with collagen (Riikonen et al., 1995a), but the
molecular mechanism of this phenomenon has been un-
clear. To study the structural requirements of signaling via
the distinct collagen receptors, we constructed a chimeric
 
a
 
 chain composed of the extracellular and transmembrane
domains of 
 
a
 
2 and the cytoplasmic domain of 
 
a
 
1. Using
this construct, we show here that the upregulation of col-
lagen 
 
a
 
1(I) mRNA levels is due to active signaling requir-
ing the cytoplasmic domain of 
 
a
 
2 subunit.
We have recently shown that in normal dermal fibro-
blasts three-dimensional collagen activates three distinct
classes of MAPKs, i.e., ERK, c-jun NH
 
2
 
-terminal kinase
(JNK), and p38 (Ravanti et al., 1999). Ligation of 
 
a
 
1
 
b
 
1
has been shown to activate the ERK kinase pathway, but
 
a
 
2
 
b
 
1 has not been previously linked to a specific MAP ki-
nase pathway. Here, we report that the 
 
a
 
2 cytoplasmic
domain–dependent regulation of type I collagen mRNA
levels requires p38 activity. We also show that the ligation
of 
 
a
 
2
 
b
 
1 leads to the activation of p38 MAPK, especially
its p38a isoform. The activation is dependent on the a2
chain cytoplasmic domain and the function of the down-
stream effectors Cdc42, MKK3, and MKK4 is required.
These results indicate a crucial role for the p38 pathway in
integrin a2b1 signaling and provide novel insight on mo-
lecular mechanisms of integrin-specific signal transduc-
tion.
Materials and Methods
Reagents
Herbimycin A, bisindoylmaleimide, KT5720, KT5723, SB 203580, PD
98059, and SKF 86002 were obtained from Calbiochem-Novabiochem
Corp. Cycloheximide was obtained from Sigma Chemical Co. (R)-(1)-
perillyl alcohol (POH) was obtained from Aldrich and anisomycin was ob-
tained from Boehringer Mannheim. a2 integrin cDNA corresponding to
nucleotides 1–4559 in the published sequence (Takada and Hemler, 1989)
and the X2C5PFNeo plasmid (Kawaguchi and Hemler, 1993) were pro-
vided by Dr. M. Hemler (Dana Farber, Boston, MA). The pAWneo2 ex-
pression vector was provided by Dr. A. Weiss (University of California
San Francisco, San Francisco, CA) (Ohashi et al., 1985). The oligonucle-
otides used were purchased from Kebo Lab. The glutathione-S-trans-
ferase (GST)–tagged ATF2 (residues 1–109) (Gupta et al., 1995), the
pRSV-MKK3(ala) and pcDNA-MKK4(ala) expression plasmids (Rain-
geaud et al., 1996; Whitmarsh et al., 1997) were provided by Dr. R. Davis
(University of Massachusetts, Worcester, MA), and flag-tagged p38 iso-
form expression vectors (New et al., 1998) were provided by Dr. J. Han
(Scripps Research Institute, La Jolla, CA). The pCEV29RhoAAsn19,
pCEV29Rac1Asn17, and pCEVCdc42Asn17 were provided by Dr. J.C. Lacal
(CSIC, Madrid, Spain). Bacterial expression of GST-ATF2 was done as
described (Smith and Johnson, 1988). The c-Jun protein was provided by
Dr. E. Coffey (Åbo Akademi University, Turku, Finland). Bacterial ex-
pression of GST-ATF2 was done as described (Smith and Johnson, 1988).
Antibody against a2 integrin, 12F1 (Pischel et al., 1987) was provided by
Dr. V. Woods (University of California, Medical Center, San Diego, CA).
Polyclonal antisera against a1 integrin cytoplasmic tail (AB1934) was pur-
chased from Chemicon International, Inc., and antibody against a1 inte-
grin used in flow cytometry, SR-84, was a gift from Dr. W. Rettig (Boeh-
ringer Ingelheim, Germany).
Cell Culture
Human osteosarcoma cell line Saos-2 was obtained from the American
Type Culture Collection. The cell cultures were maintained in DME
supplemented with heat inactivated 10% FCS (GIBCO-BRL), 2 mM
glutamine, 100 IU/ml penicillin-G, and 100 mg/ml streptomycin.
Plasmid Constructs and Stable Transfections
The a2 integrin expression construct was prepared as described previously
(Riikonen et al., 1995a). The mutant a2 subunit, in which the cytoplasmic
tail has been replaced with the corresponding a1 integrin sequence, was
prepared in the following way. A silent point mutation (nucleotide 3488 in
the published sequence; Takada and Hemler, 1989) that introduces a new
NheI recognition site was made with the Altered sites II in vitro mutagen-
esis system (Promega) according to the manufacturer’s instructions. The
mutant oligo used was ACCAGAGCTAGCAGCAAAAGG. The a2
cDNA was digested with NheI and SacI cleaving the region corresponding
to the a2 cytoplasmic tail. The a1 DNA was obtained by annealing sense
and antisense synthetic nucleotides corresponding to nucleotides 3506–
3543 in the published a1 sequence (Briesewitz et al., 1993) flanked with
corresponding a2 sequences; antisense oligo (TTTTGCTGCTAGCTC-
TGGTTGCAATTTTATGGAAGCTCGGATTCTTCAAAAGACCA-
CTGAAAAAGAAAATGGAGAAATGAGAGCTCAGTAGCTG),
sense oligo (TCAGCTACTGAGCTCTCATTTCTCCATTTTCTTTTT-
CAGTGGTCTTTTGAAGAATCCGAGCTTCCATAAAATTGCAA-
CCAGAGCTAGCAGCAAAA). This synthetic DNA fragment was di-
gested with NheI and SacI restriction enzymes and ligated with the
cleaved a2 cDNA. The correctness of the construct was checked by se-
quencing. Stable transfections were performed with the calcium polybren/
DNA method on confluent 60-mm dishes. Incubation with 5 mg DNA and
5 mg polybren in 1 ml 10% FCS/DME per dish was carried out for 6 h, ag-
itating the dishes once an hour. DMSO (30% in FCS) shock was done for
3 min, cells were washed twice with PBS, and culture medium was added.
Neomycin analogue G418 (Life Technologies, Inc.) was added to the cul-
ture medium in a concentration of 400 mg/ml. G418-resistant cell clones
were selected for 2–3 wk, isolated, and analyzed for their expression of a2
integrin. Control cells were transfected with the pAWneo2 plasmid only.Ivaska et al. a2b1 Integrin Activates p38a 403
Transfected  cells were cultured in 10% FCS/DME containing 2 mM
glutamine, 100 IU/ml penicillin-G, 100 mg/ml of streptomycin and 200 mg/
ml G418.
Collagen Gels and Gel Contractions
Collagen gels were prepared from bovine dermal collagen, which contains
95% type I collagen and 5% type III collagen (Cellon). 8 vol of Cellon
were mixed with 1 vol of 103 concentrated DME and 1 vol of 103 con-
centrated NaOH (0.05 M) in Hepes buffer (0.2 M) and kept on ice. Cells
were trypsinized, resuspended in 1/10 gel volume culture media DME
supplemented with 10% FCS, mixed into neutralized Cellon solution, and
transferred into 6-well plates. The collagen was allowed to polymerize for
2 h at 378C, after which the culture media containing 10% FCS was added,
the gels were detached from the sides of the wells, and incubation was
continued for the times indicated. Cells were also cultured on plastic as a
monolayer in culture media containing 10% FCS. In experiments involv-
ing inhibitors, the cells were pretreated with the inhibitor for 30 min at
room temperature before mixing the cells with the neutralized Cellon so-
lution, also supplemented with the inhibitor at the concentrations indi-
cated. After polymerization, culture media containing 10% FCS and the
inhibitor was added and the gels were detached from the sides of the
dishes. Incubation was continued for 48 h. When studying collagen gel
contraction, cell culture wells were photographed after 48 h and the sur-
face areas of the gels were measured from the prints.
Immunofluorescence
The cells grown on immunofluorescence glass slides (CML) covered or
uncovered with collagen film (Cellon) were rinsed with PBS and fixed
with methanol at 2208C for 5 min. The cells grown inside collagen gels
were excised from culture wells, embedded in OCT compound (Tissue-
Tek; Miles Scientific), and frozen in isopentane chilled with liquid nitro-
gen. Sections of 10-mM thickness were cut and picked up onto microscope
slides and treated as described above. The slides containing the fixed sam-
ples were incubated in 2% BSA in PBS and monoclonal anti–CD49b anti-
body (Chemicon International Inc.) was added to the same solution and
incubated 30 min at room temperature. After rinsing, the cells were incu-
bated with anti–mouse–FITC conjugate (Dako A/S) for 30 min and
mounted before observation and photography. For staining of the actin
filaments, plastic coverslips (Nunc) were coated with PBS containing 16
mg/ml type I collagen overnight at 48C and blocked with 1% BSA in PBS
for 1 h at 378C. Cells were allowed to adhere and spread on collagen
coated coverslips for 24 h in DME. Coverslips were washed once with
PBS and fixed with 2% paraformaldehyde, permeabilized with 0.5% Tri-
ton X-100 in PBS for 10 min, and incubated with rhodamine-conjugated
phalloidin (Sigma Chemical Co.) 1:1,000 in PBS for 30 min. Cells were
washed with PBS and mounted before observation and photography.
Northern Blot Hybridizations
Total cellular RNA was isolated using the Qiagen RNeasy kit. Total RNA
was separated in formaldehyde-containing agarose gels, transferred to ny-
lon membranes (Zeta-probe; Bio-Rad Laboratories), and hybridized with
32P-labeled (Amersham) cDNA probes. The following cDNAs were used:
human a2 integrin (Takada and Hemler, 1989), human collagen a1(I)
(Mäkelä et al., 1988), human collagen a2(I) (Mäkelä et al., 1990) and 28S
(a gift from R. Penttinen, University of Turku), and rat glyceraldehyde-
3-phosphate dehydrogenase (GAPDH; Fort et al., 1985).
Flow Cytometry
Cells were grown to early confluence, detached with trypsin-EDTA, and
trypsin activity was inhibited by medium supplemented with serum. Cells
were washed with PBS, pH 7.4, and then incubated with PBS containing
10 mg/ml BSA, 1 mg/ml glycine, and 0.02% NaN3 for 20 min at 48C. Cells
were collected by centrifugation, exposed to saturating concentration of
mAb against a2 integrin (12F1) or a1 integrin (SR-84) in BSA/PBS (BSA
concentration 1 mg/ml) containing NaN3 for 30 min at 148C, and stained
with rabbit anti–mouse IgG coupled to fluorescein (1:20 dilution; Dako A/S)
for 30 min at 48C. Cells were washed twice with PBS containing NaN3 and
suspended in the same buffer. To measure the amount of a2 integrin on
the cell surfaces, the fluorescent excitation spectra were analyzed by using
a FACScan apparatus (Becton Dickinson). Control samples were pre-
pared by treating the cells without primary antibodies.
Immunoprecipitation of Integrin from Metabolically 
Labeled Cells
Cells were metabolically labeled with 100 mCi/ml of [35S]methionine
(Tran[35S]-label, ICN Biomedicals Inc.) for 16 h in methionine-free mini-
mum essential medium. Cell monolayers were rinsed on ice with a solu-
tion containing 150 mM NaCl, 1 mM CaCl2, 1 mM MgCl2, and 25 mM
Tris-HCl, pH 7.4, and then detached by scraping. Cell pellets were ob-
tained by centrifugation at 500 g for 5 min. Cells were solubilized in 200 ml
of the same buffer containing 100 mM N-octyl-b-D-glucopyranoside
(Sigma Chemical Co.) on ice with occasional vortexing. Insoluble material
was removed by centrifugation at 10,000 g for 5 min at 48C. Radioactivity
in cell lysates was counted and an equal amount of radioactivity was used
in immunoprecipitation assays. Triton X-100 (0.5% vol/vol) and BSA (0.5
mg/ml) were added to the supernatants, which were precleared by incuba-
tion with 50 ml of packed protein A–Sepharose (Pharmacia LKB Biotech-
nology Inc.). Supernatants were immunoprecipitated with antiintegrin an-
tibody (12F1 or AB1934) for 12 h at 48C followed by incubation with
secondary antibody (rabbit anti–mouse, DAKO), when 12F1 was used.
Immune complexes were recovered by binding to protein A–Sepharose
and washing the beads four times with 25 mM Tris-buffered isotonic sa-
line, pH 7.4, containing 0.5% Triton X-100 and 1 mg/ml BSA and twice
with 0.5 M NaCl and 25 mM Tris-HCl, pH 7.4. The immunoprecipitates
were analyzed by electrophoresis on SDS-containing 6% polyacrylamide
gels under nonreducing conditions followed by fluorography.
Transcriptional Nuclear Run-on Analyses
The cells were lysed with NP-40 (ICN) and the nuclei were isolated by
centrifugation (12,000 g) for 3 s at 48C. The nuclei were incubated in the
presence of 100 mCi of [a-32P]UTP (3,000 Ci/mmol, NEN) for 30 min at
room temperature as described previously (Banerji et al., 1984). Radiola-
beled RNA was hybridized with 2 mg of nitrocellulose-fixed plasmids:
cDNAs for human a1(I) collagen, human a2(I) collagen, GAPDH, and
pBluescript (Stratagene). The hybridization and washing conditions used
were as described previously (Sistonen et al., 1992). Quantitation was per-
formed with GS-250 Molecular Image System (Bio-Rad Laboratories)
and the results were corrected for the levels of GAPDH transcripts in the
same samples.
Cell Spreading Assays
The coating of a 96-well immunoplate (Maxi Sorp; Nunc) was done by ex-
posure to 0.2 ml of PBS, pH 7.4, containing 0.1 mg/cm2 (1.64 mg/ml) type I
collagen (from lathyric rat skin, Boehringer Mannheim) for 12 h at 378C.
Residual protein absorption sites in all wells were blocked with 1% BSA
in PBS for 1 h at 378C. BSA was also used to measure the nonspecific
binding. Cells were detached by using 0.01% trypsin and 0.02% EDTA.
Trypsin activity was inhibited by washing the cells with 1 mg/ml of soy-
bean trypsin inhibitor (Sigma Chemical Co.). In cell spreading assays, cells
were suspended in DME with 50 mM cycloheximide (Sigma Chemical
Co.), transferred into each well, and incubated for 35 min at 378C. The
wells were washed with PBS and fixed with 8% formaldehyde and 10%
sucrose in PBS for 30 min. The total number of cells attached per one mi-
croscopic field and the percentage of spread cells were counted. A spread
cell was characterized as one having a clearly visible ring of cytoplasm
around the nucleus.
Assay of MAPK Activation
The activation of ERK1 and 2, JNK/SAPK, and p38 MAPK was determined
by Western blotting using antibodies specific for the phosphorylated, acti-
vated forms of the corresponding MAPKs (New England Biolabs). The
control blots for the total (phosphorylated and nonphosphorylated forms)
protein levels were done by using antibodies recognizing the correspond-
ing MAPKs (p38, ERK2, New England Biolabs; JNK1, Santa Cruz Bio-
technology). Saos cell clones were either grown in monolayer for 24 h or
seeded in collagen gels as described earlier. Once polymerized, the gels
were detached from the dish and incubated for the time indicated. The
cells were released from the gels as described above and lysed in 100 ml of
Laemmli sample buffer. Cells grown in monolayer were washed once with
warm PBS and lysed in 100 ml of Laemmli sample buffer. The positive
control treatment for the JNK Western blot was done by treating cells in
suspension with 10 mg/ml anisomycin (Boehringer Mannheim). The sam-
ples were sonicated, fractionated by 10% SDS-PAGE, and transferred toThe Journal of Cell Biology, Volume 147, 1999 404
a Hybond ECL membrane (Amersham Corp.). Western blotting was per-
formed as described previously (Reunanen et al., 1998), with phosphospe-
cific antibodies in dilution 1:1,000. Specific binding of antibodies was de-
tected with peroxidase-conjugated secondary antibodies and visualized by
enhanced chemiluminescence (ECL) detection system (Amersham).
In Vitro p38 and JNK Kinase Assay and Western Blot 
Analysis of Flag-tagged Protein
Subconfluent Saos cell clones plated on 60-mm dishes were transfected us-
ing 4 ml of Fugene 6 transfection reagent (Boehringer Mannheim) and 2 mg
of either eukaryotic expression vector alone (pcDNA3; Invitrogen Corp.)
or the same vector containing the flag-tagged p38 isoform (New et al.,
1998). Cotransfection of dominant negative signaling proteins was done
by using 12–16 ml of Fugene 6, 3–8 mg of empty expression vector or the
same vector containing the effector mutant and 2 mg of flag-tagged p38a.
36 h after transfections, the cells were treated with collagen gel for 3 h as
described earlier or left untreated. Cells were solubilized with RIPA
buffer (1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 1 mM EDTA, 1
mM EGTA, 1 mM sodium orthovanadate, 20 mM sodium fluoride, 0.5
mM DTT, 1 mM PMSF in PBS, pH 7.4) supplemented with leupeptin, an-
tipain, and pepstatin, 2 mg/ml each. The extracts were centrifuged 3,000
rpm for 15 min at 48C. 1 mg of M2 antibody (Eastman Kodak Co.) conju-
gated to protein G–Sepharose (Pharmacia-LKB Biotechnology) was used
for immunoprecipitation. The immunoprecipitates were washed twice
with RIPA buffer, once with LiCl wash buffer (500 mM LiCl, 100 mM
Tris, pH 7.6, 0.1% Triton X-100, 1 mM DTT) and once with kinase buffer
(20 mM MOPS, pH 7.2, 2 mM EGTA, 10 mM MgCl2, 0.1% Triton X-100,
1 mM DTT). The kinase assay was initiated with 2 mg GST-ATF2 as sub-
strate and 50 mM MgCl2, 25 mM ATP, 3 mCi g-[32P]ATP in a final volume of
50 ml. The reactions were terminated after 30 min at 378C by the addition
of Laemmli sample buffer. The phosphorylation of substrate protein was
examined after SDS-PAGE by autoradiography. For Western blotting,
samples of lysed cells were fractionated by 10% SDS-PAGE and trans-
ferred to Hybond ECL membrane (Amersham Corp.). Western blotting
was performed as described previously (Reunanen et al., 1998), with M2
antibody (Eastman Kodak Company) in dilution 1:750. Specific binding
of antibodies was detected with peroxidase conjugated secondary anti-
mouse antibody and visualized by the ECL detection system (Amersham).
The JNK kinase assay was done as described in Westermarck et al.
(1998) with some modifications, namely the antibody used was anti-JNK1
(Santa Cruz Biotechnology) and the immunoprecipitation was done with
protein G–Sepharose. The cells were brought into suspension, counted,
and diluted so that equal number of cells from both clones were used. The
cells were then either lysed immediately, treated with anisomycin for 10
min or seeded inside collagen for 3 h.
Immunoprecipitation of FAK and Western
Blot Analysis
The cells were brought into suspension, counted, and diluted so that equal
number of cells from both clones were used. The cells were either lysed
immediately or allowed to adhere to fibronectin (1 mg/cm2 coated on a 60-
mm dish overnight at 148C and blocked with 0.1% heat-inactivated BSA
for 1 h at 1378C) or seeded inside collagen for 1 h. The assay was done as
described previously (Elenius et al., 1997). The antibody used for immu-
noprecipitation was polyclonal anti-FAK (Upstate Biotechnology Inc.).
The filter was first blotted with antiphosphotyrosine (4G10; Upstate Bio-
technology Inc.), stripped according to manufacturer’s instructions, and
reprobed with anti–FAK antibody. Alternatively, total cell lysates were
fractionated by SDS-PAGE and the filter was first blotted with an anti-
body mixture detecting all the phosphorylated forms of FAK (Biosource,
Hopkinton, MA), following stripping and re-probing with anti-FAK anti-
body.
Results
Chimeric a2/a1b1 Integrin Functions like the
Wild-type a2b1 Receptor in the Formation of
Focal Contacts
Initially, we made stable transfectants expressing wild-
type  a2 or chimeric a2/a1 subunit using Saos-2 cells, which
have endogenous a1b1 but no a2b1 (Vihinen et al., 1996).
Flow cytometric analysis using anti–a2 mAb (Fig. 1 B)
confirmed that both the wild-type and the chimeric recep-
tor were expressed on the surface of the transfected cells.
Based on the flow cytometric measurements, we selected
cell clones with similar expression levels of wild-type a2 or
chimeric a2/a1 integrin to be used in the experiments (Fig.
1 B). Also, the cell clones used in the experiments and not
shown in the Fig. 1 B were tested. In addition, we mea-
sured the expression levels of a1b1 from both mock-trans-
fected and a2-transfected cells to ensure that the a2
cDNA transfections did not alter the expression of the en-
dogenous a1b1. The average levels of a1 integrin on four
independent single cell clones tested were 60.8 6 3.8 (arbi-
trary units) in mock-transfected cells and 68.3 6 8.6 in
a2-transfected cells. The corresponding values for a2 inte-
grin were 13.5 6 0.7 (represents negative background level
fluorescence) and 362 6 54. Immunoprecipitation experi-
ments were performed to confirm that the chimeric a2/a1
subunit was associated with the endogenous b1 subunit to
form a typical heterodimeric ab complex. The chimeric
structure of the heterodimer was verified using an anti-
body recognizing the a1 cytoplasmic tail (not shown).
Deletion of the a2 cytoplasmic domain has been shown
to result in ligand-independent recruitment of the integrin
to preformed focal contacts (Kawaguchi et al., 1994). To
study if swapping of the a2 cytoplasmic domain to the
significantly shorter a1 tail results in indiscriminate inte-
grin recruitment into focal adhesion sites formed by other
integrins, we studied both wild-type a2 and chimeric a2/a1
in Saos-2 cells spread on serum proteins. Both clones
showed a diffuse staining pattern indicating that the recep-
Figure 1. (A) The cDNA constructs used in the transfections.
(B) Flow cytometry analysis showing surface expression of a2 in-
tegrin subunit. The stable transfected cell clones were exposed
to saturating concentration of monoclonal antibody against a2
integrin (12F1). Bound antibody was detected with FITC-conju-
gated rabbit anti–mouse IgG.Ivaska et al. a2b1 Integrin Activates p38a 405
tors do not localize to focal contacts ligand independently
(Fig. 2 A, a and b). When these clones were allowed to ad-
here to and spread on collagen in serum-free conditions
both wild-type and chimeric receptors were able to form
focal contacts (Fig. 2 A, c and d) indicating that the a2
chain cytoplasmic tail can be replaced with the corre-
sponding a1 sequence without affecting cellular localiza-
tion of the receptor. Also, the formation of actin stress fi-
bers on collagen was similar in both clones (Fig. 2 B). In
cells cultured inside three-dimensional collagen, no aber-
rant clusters of integrins were seen and both receptors
showed a diffuse staining pattern (Fig. 2 A, e and f). 
a2 Cytoplasmic Tail Is Required for Fast Spreading on 
Collagen and Collagen Gel Contraction
Cell adhesion to type I collagen was studied to determine
the effect of swapping the tails on the adhesive properties
of the integrin. Adhesion mediated by the chimeric a2/
a1b1 receptor was found to be equivalent to that of the
wild-type receptor (Fig. 3 A). Both the wild-type a2-trans-
fected cells and the a2/a1 chimera–transfected cells ad-
hered to collagen at the early time point studied (1 h)
more efficiently than the mock-transfected cells. When
studying focal contact formation by a2 wild-type and chi-
meric  a2/a1–transfected clones, we noticed that even
though cell adhesion to collagen was not influenced by the
replacement of the a2 cytoplasmic tail with the a1 tail, the
efficiency of the clones to spread on collagen was some-
what different. The cells expressing a2 wild-type receptor
spread faster than cells expressing a2/a1 chimeric recep-
tor, so that after 30 min on collagen 61.5 6 6% of adherent
a2-transfected cells had spread, whereas only 43 6 8.3%
of adherent a2/a1–transfected cells had spread (Fig. 3 B).
At this early time point, mock-transfected cells expressing
only  a1b1 had just begun to adhere and virtually no
spreading was seen. At later time points (i.e., 2 h and
later), also the mock-transfected cells spread efficiently on
collagen. Since both a2 wild-type and a2/a1 chimeric re-
ceptor were expressed at similar levels on the cell surface
(Fig. 1 B), the small difference seen in cell spreading may
indicate that the cytoplasmic tail of a2 functions in linking
the integrin to the cytoskeleton in a manner promoting
spreading on collagen. Therefore, we wanted to study the
ability of a2 cytoplasmic tail to mediate cytoskeleton-
dependent events and assayed the ability of a2- and a2/
a1–transfected cells to contract collagen gels. As expected,
vector control cells, having endogenous a1b1 but no a2b1,
showed very weak contraction during the 72-h experiment
(area of the gel 1.8 6 0.35-fold reduced), whereas wild-
type  a2b1-expressing cells contract the gel efficiently
(area of the gel 4.0 6 1.0-fold reduced) (Fig. 3 C). The cy-
Figure 2. Characterization of the cellular location of a2 and a2/a1 integrin and
formation of actin stress fibers. Stable Saos-2 transfectants were either grown in
DME 10% FCS on immunofluorescence glass slides, plated on collagen coated
glass slides, and allowed to adhere for 4 h in DME (serum-free) or grown inside a
three-dimensional collagen gel for 48 h. (A) After incubation, the cells were fixed
and stained for a2 integrin by using mAb followed by FITC-labeled rabbit anti–
mouse antibody. Cells were washed, mounted, and examined on a microscope: (a)
a2 clone 47 and (b) a2/a1 clone 18 on serum-derived fibronectin and vitronectin;
(c) a2 clone 47 and (d) a2/a1 clone 18 on collagen; (e) a2 clone 47 and (f) a2/a1
clone 18 inside collagen gel; and (g) vector clone as a negative control. (B) Cells
were stained for actin using fluorescein-conjugated phalloidin (a) a2 clone 47 and
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toplasmic tail of a2 seemed to be essential for linkage of
the integrin to the cytoskeletal machinery since the cells
expressing chimeric a2/a1 failed to contract the collagen
gel (Fig. 3 C).
Integrin a2 Cytoplasmic Tail Is Required for the 
Upregulation of Collagen a1(I) and a2(I) Gene 
Expression at the Transcriptional Level
Overexpression of the wild-type a2 in Saos-2 cells resulted
in upregulation of the mRNA levels of both collagen a1(I)
(1.4–4.3-fold) and a2(I) (3.3-fold) in response to three-
dimensional collagen matrix. To test the generality of this
observation, all together three independent single cell
clones overexpressing a2b1 were tested (not shown). In
contrast, vector control cells showed a downregulation
ranging from 0.8 to 2.4-fold for collagen a1(I) mRNA (Fig.
4, A and B). Interestingly, the chimeric receptor failed to
mediate upregulation of the collagen mRNAs in response
to three-dimensional collagen matrix as seen with the
Northern blot hybridization of total RNA isolated from
two single cell clones pooled together. The mRNA levels
of collagen a1(I) in cells expressing the chimeric receptor
were downregulated by 1.5–1.8-fold in response to col-
lagen compared with the average 3.6-fold upregulation
seen in cells expressing the a2 wild-type receptor (Fig. 4,
A and B). Also, expression of collagen a2(I) was downreg-
ulated in the a2/a1–transfected cells. These results were
again confirmed to be reproducible with RNA from a
third independent single cell clone (not shown). Alto-
gether, cells transfected with the chimera responded to
collagen identically to the mock-transfected cells. Integrin
a1b1 is known to function as a negative regulator of col-
lagen (Langholz et al., 1995; Riikonen et al., 1995a). The
transmembrane region of this receptor has been suggested
to signal through interaction with caveolin (Wary et al.,
1996), whereas the possible signaling function of a1 cyto-
plasmic domain cannot be excluded. In the a2/a1–trans-
fected cells, no further reduction of collagen levels was
seen when compared with the mock-transfected cells hav-
ing endogenous a1b1 integrin, suggesting that the short a1
cytoplasmic tail is not alone sufficient to regulate collagen
gene expression. To test this further, we transfected Saos-2
cells with the X2C5PFNeo plasmid coding for a2 subunit
with a5 cytoplasmic tail (Kawaguchi and Hemler, 1993).
Again, similarly as both the mock-transfected and the a2/
a1–transfected cells, collagen mRNA levels were de-
creased in response to collagen (not shown).
To assess the contribution of increased transcription of
collagen a1(I) on this elevation seen in mRNA levels, we
performed nuclear run-on experiments. Nuclei were iso-
lated from a2- or a2/a1–transfected cells grown either in
monolayer or in three-dimensional collagen gel for 48 h.
The rate of the collagen gene transcription was compared
with that of GAPDH. A 1.8-fold increase of transcription
was seen in a2-transfected clones cultured in three-dimen-
sional collagen when compared with the rate of transcrip-
tion in cells grown in monolayer (Fig. 4 C). In contrast,
cells transfected with the chimeric a2/a1 chain showed a
1.5-fold decrease in transcription rate (Fig. 4 C). Even
though the increased transcription rate of collagen a1(I)
gene accounted for most of the upregulation seen in a2b1-
overexpressing clones, we also wanted to investigate the
stability of the mRNAs. We used actinomycin D to block
transcription in cell clones grown in monolayer and in col-
lagen gels. Type I collagen mRNAs seem to have rela-
tively long half-lives (.8 h) in Saos-2 cells transfected with
wild-type a2, but no obvious difference was seen between
Figure 3. Cell–collagen interaction of
stable transfected human osteosarcoma
Saos-2 expressing wild-type a2 integrin,
chimeric a2/a1 integrin or empty vec-
tor. The data shown are the mean val-
ues 6 SD of a representative experi-
ment done in triplicate. (A) Cell
adhesion to type I collagen was studied.
10,000 cells were suspended in DME
(serum-free), then transferred into
wells coated with indicated concentra-
tions of type I collagen. After 1 h the
nonadherent cells were washed out and
the adherent ones were stained with
crystal violet. Cell-bound stain was dis-
solved and measured spectrophotomet-
rically. (B) Cell spreading on type I col-
lagen and fibronectin was studied.
10,000 cells were suspended in DME
with 50 mM cycloheximide, and then
transferred into wells coated with dif-
ferent matrixes. After 30 min the non-
adherent cells were washed out and the
adherent ones were fixed. The percent-
age of spread cells was counted. (C) The ability of various collagen receptor integrins to mediate collagen gel contraction was tested us-
ing stable transfected clones of human osteosarcoma Saos-2 cells (mock-, a2-, or a2/a1–expressing clones). 5 3 105 cells were seeded in-
side a collagen gel, the polymerized gel was detached from the sides of the dish and the cells were cultured for 3 d in DME 10% FCS.
The gels were photographed and surface areas of the gels were measured.Ivaska et al. a2b1 Integrin Activates p38a 407
the various culture conditions. Both in monolayer and in
three-dimensional matrix collagen, mRNA levels were re-
duced by z50% after 8 h treatment with actinomycin D
(Fig. 4 D).
a2b1 Integrin-mediated Upregulation of Collagen a1(I) 
Expression in Three-Dimensional Collagen Requires 
p38 MAP Kinase Pathway
To identify the downstream components of a2b1-medi-
ated upregulation of collagen gene expression, we tested
specific inhibitors at concentrations sufficient to inhibit
various signaling kinases (Alessi et al., 1995; Dudley et al.,
1995; Broberg and Heino, 1996). The cells were exposed to
inhibitors before seeding them inside collagen. Of the
various compounds tested, the p38 inhibitor, SB203580,
showed the most potent inhibition of collagen a1(I) gene
expression (5.5-fold) in a2b1-overexpressing cells grown
in three-dimensional collagen gel (Fig. 5 A). The com-
pounds that showed some inhibition (about twofold) included
tyrosine kinase inhibitor herbimycin A, PKG inhibitor
KT5823, PKA inhibitor KT5720, and Ras farnesylation in-
hibitor (R)-(1)-Perillyl alcohol (POH), whereas MEK in-
hibitor PD98059 had no effect. High concentrations of the
PKC inhibitor bisindolylmaleimide resulted in downregu-
lation of collagen mRNA levels (twofold at 5 mM and 4.1-
fold at 20 mM concentrations), but this effect was seen in
both a2- and mock-transfected cells and was therefore
considered to be nonspecific. In addition, phosphatidyl-
inositol-3-kinase (PI-3K) inhibitor, wortmannin treatment
resulted in a slight reduction of collagen a1(I) mRNA
in a2-transfected cells (not shown) and this effect was
smaller in vector-transfected cells (Fig. 5 A). The small ef-
fects of various inhibitors suggest that corresponding sig-
naling proteins might participate in integrin signaling,
but this hypothesis was not studied further. Another spe-
cific inhibitor targeting the p38 MAP kinase pathway,
SKF86002, was tested to confirm the result obtained with
SB203580. Treatment with this compound also resulted in
concentration-dependent inhibition of a2b1-mediated up-
regulation of collagen a1(I) mRNA levels (6.1-fold at 10
mM and 9.5-fold at 20 mM). 20 mM SB203580 was a potent
inhibitor of collagen mRNA levels in a2-transfected cells
inside collagen (Fig. 5 B), but it had no effect on mRNA
levels in mock-transfected cells inside collagen (Fig. 5 A)
or a2-transfected cells in monolayer (Fig. 5 C), excluding
the possibility that the compound could function as a gen-
eral downregulator of collagen gene expression.
Three-dimensional Collagen Gel Induce Isoform 
Specific Activation of p38a in Saos-2 Cells and the 
Efficient Activation Requires a2 Cytoplasmic Tail
The ability of the selective p38 inhibitors, SB203580 and
Figure 4. Effect of matrix on the ex-
pression level of collagen a1(I) and col-
lagen  a2(I) mRNAs, transcriptional
regulation and mRNA stability of col-
lagen a1(I) in Saos-2 cells expressing
either wild-type a2 or chimeric a2/a1
integrin. Mock-, a2-, and a2/a1–trans-
fected cells were cultured in a mono-
layer (M) or inside collagen gel (C) for
48 h. Total RNA was isolated, sepa-
rated by electrophoresis, and trans-
ferred to filters. Specific mRNA levels
were analyzed with corresponding
cDNA probes. 28S ribosomal RNA was
used as a control. (A) Autoradiograms
of a representative experiment and (B)
quantitative analysis of an identical
separately performed experiment was
done by an image analyzer. (C) Nuclear
run-on assay was performed with nuclei
from Saos-2 cells grown either in mono-
layer or inside three-dimensional col-
lagen gels 48 h before harvest. Nascent
32P-labeled RNA was hybridized to ni-
trocellulose filter-immobilized cDNA
probe. Quantitative analysis was per-
formed with an image analyzer system.
The values for the collagen a1(I) gene
transcription were corrected to
GAPDH transcription in the same sam-
ple. The data shown are mean 6 range
of a representative experiment done in
duplicate. (D) mRNA stability assay
using actinomycin. Cells were cultured for 24 h before adding actinomycin D (6.4 mg/ml) either inside collagen gel or in monolayer. To-
tal RNA was isolated from cells after 8 h. Autoradiograms from Northern blot analysis using collagen a1(I) cDNA and 28S cDNA as
control are shown. Quantitative analysis of the experiment was done with an image analyzer system.The Journal of Cell Biology, Volume 147, 1999 408
SKF86002, to inhibit a2 cytoplasmic tail–dependent up-
regulation of collagen mRNA levels lead us to study how
p38 activity is regulated in response to collagenous ma-
trix in these cells. We examined the activation of p38 by
using a phosphospecific antibody that recognizes phos-
phorylated p38a and p38b isoforms. The cells expressing
wild-type a2 showed a marked activation (fivefold) al-
ready at 2 h after seeding the cells inside collagen. The
activation gradually decreased during the next 12 h, but
remained at levels threefold higher than the 0 h time
point (Fig. 6 A). To study whether this activation was due
to signaling via the a2b1, we analyzed the levels of phos-
phorylated p38 in cells expressing chimeric a2/a1 chain.
In three separate experiments using different single cell
clones, the wild-type a2-expressing cells showed in aver-
age 2.3-fold higher levels of active p38 2 h after seeding
the cells inside collagen gel than cells expressing chimeric
a2/a1 chain. Protein levels of p38 remained constant at
all time points, as shown with the control antibody recog-
nizing both activated and inactivated forms of p38b (Fig.
6 B). At a later (24 h) time point, the p38 activation per-
sisted and a2-transfected cells showed a higher level of
activation than the cells expressing chimeric a2/a1 chain
(Fig. 6 C). To confirm this difference in the levels of ac-
tive p38 at the 24-h time point, the experiment was re-
peated five times using four or five parallel samples and
two individual single cell clones of both transfections. In
all experiments, p38 was activated in response to three-
dimensional collagen and, in cells expressing the wild-
type a2 chain, the levels were on average 1.9-fold higher
(range, 1.3–3.5-fold). The difference in levels of active
p38 between the a2 and a2/a1 cells were found to be sta-
tistically significant when the results of all five experi-
ments were combined together (two-way analysis of vari-
ance; P , 0.0001). Finally, to confirm that this difference
is the result of signals dependent on the a2 cytoplasmic
tail in response to collagen, we tested the levels of active
p38 in the same cell clones when grown in monolayer.
The overall levels of active p38 were relatively low and
no significant difference between the clones was detected
(Fig. 7 D).
To date, the p38 MAP kinase group is known to include
five isoforms: p38a (Lee et al., 1994), p38b (Jiang et al.,
1996), p38b2 (Enslen et al., 1998), p38g (Cuenda et al.,
1997), and p38d (Jiang et al., 1997; X.S. Wang et al., 1997).
To study whether a2b1 cytoplasmic tail could specifically
activate some isoform of p38, we overexpressed various
forms of flag-tagged p38 kinases (New et al., 1998) in Saos
cell stable clones expressing either wild-type a2 or chi-
meric a2/a1. The transfected cells were seeded inside a
collagen gel, after 3 h the cells were collected, flag-tagged
p38 was immunoprecipitated, and an in vitro kinase assay
was performed. As seen in Fig. 6 E, p38a isoform was acti-
vated efficiently in a2-transfected cells (activity 0.47 units;
arbitrary units 5 densitometric units 2 background),
whereas in a2/a1–transfected cells the activity was 0.03.
No activation of p38b2 was detected (a2 clone 45 5 0.04
and a2a1 clone 12 5 0.02). p38g showed high activity in
both cell clones (a2 clone 45 5 0.24 and a2/a1 clone 12 5
0.32) and p38d activity was high in both clones (a2 clone
45 5 0.64 and a2/a1 clone 12 5 0.23). The results were
confirmed with two individual a2- or a2/a1–expressing
clones (Fig. 6 F). The expression levels of the transiently
transfected kinases in various clones were equal as shown
by Western blot analysis done by using antibody against
the flag-tag.
The Effect of p38 Inhibitors SB203580 and SKF86002 
on the Various p38 Isoforms Expressed in
a2-Transfected Saos-2 Cells
As seen in Fig. 6, E and F, p38a was activated only in a2-
transfected cells and no activation of p38b2 was seen.
Figure 5. Effects of different signaling pathway inhibitors on the
expression level of collagen a1(I) and collagen a2(I) mRNAs.
Cells were cultured in a monolayer or inside collagen gel for 2 d
in the presence of inhibitors indicated (20 mM SB203580, 40 mM
PD98059, 35 nM herbimycin A, 150 nM KT5723, 100 nM
KT5720, 100 mM and 500 mM (R)-(1)-Perillyl alcohol (POH), 10
and 20 mM SKF86002). Total RNA was isolated, separated by
electrophoresis, and transferred to filters. Specific mRNA levels
were analyzed with corresponding cDNA probes. 28S ribosomal
RNA was used as a control. (A) Cells from two separate single
cell a2 clones 45 and 47 were pooled together for the study, auto-
radiograms are shown. (B) The effect of SB203580 on the expres-
sion level of collagen a1(I) mRNA was studied with mock-trans-
fected clones 3 and 15, and a2 clones 45 and 47 cultured inside
collagen gel for 48 h, quantitative analysis of the expression levels
relative to collagen gel control levels are shown. The data are
mean of two separate experiments each with a different single
cell clone 6 range. (C) Autoradiogram showing the effect of
SB203580 on the expression level of collagen a1(I) mRNA in a2
clone 47 grown in a monolayer for 48 h.Ivaska et al. a2b1 Integrin Activates p38a 409
However, equally high activity of p38g was seen in both
a2- and a2/a1–transfected cells and the p38d activity was
higher in a2 cells than in a2/a1 cells. To study which of
these activated kinases are relevant to the a2-mediated
upregulation of collagen, shown to be inhibited by chemi-
cal inhibitors (SB203580 and SKF86002), we tested the ef-
fect of these inhibitors in an in vitro kinase assay. a2-
transfected Saos-2 cells were transiently transfected with
flag-tagged p38 isoforms (a, b2, g, or d), the cells were
treated with collagen and the kinase activity of each iso-
Figure 6. The regulation and isoform-
specific activation of p38 by a2b1 inte-
grin in response to matrix. (A) Cells
from two separate a2 single cell clones
(45 and 47) were pooled together and
seeded in collagen gel and incubated
for different periods of time, as indi-
cated. The levels of activated p38a and
p38b (p38-P) were determined by
Western blot analysis using a phospho-
specific antibody for p38a and b, anti-
body recognizing all forms of p38 was
used as a control. The levels of acti-
vated p38 were quantitated by using an
image analyzer system and are shown
relative to the levels of total p38
present in each sample. (B) To test the
role of the a2 cytoplasmic tail, the ex-
periment was done with 0 h in the 2-h
time points using both a2-transfected
clones (45 and 47) and a2/a1–trans-
fected clones (12 and 2). The levels of
activated p38 were quantitated by using
an image analyzer system and are
shown relative to the levels of total p38
present in each sample. The data are
mean of three separate experiments
with different single cell clones 6 SD.
Autoradiogram of a representative ex-
periment done in duplicate showing
p38-P levels at 2-h time point is shown.
(C) Levels of active p38 after 24 h cul-
ture of cells inside collagen gel. The
data shown are mean 6 SD of a repre-
sentative experiment done in quadru-
plicate. **, P , 0.001. (D) Activation of
p38 in a2 and a2/a1–transfected Saos-2
cells grown on a monolayer. Cells from
two separate a2 cell clones (45 and 47)
or a2/a1 clones (2 and 12) were pooled
together and grown in a monolayer for
24 h. (E) Equal numbers of stable
transfected Saos-2 cells were tran-
siently transfected with flag-tagged p38
isoforms (a, b2, g, or d) and treated and
assayed for p38 kinase activity. The lev-
els of phosphorylated ATF-2 were
quantitated using an image analyzer
system and are shown as levels of
ATF-2 phosphorylation with back-
ground correction (signal from control
transfected cells subtracted). a2 clone
45 and a2/a1 clone 12 were transfected
with either the control vector or the p38
isoforms indicated (F) a2 clones (45
and 47) and a2/a1 clones (2 and 12)
were transfected with control vector,
p38a, or p38b2. Expression of the two
flag-tagged isoforms was checked with
Western blot analysis using flag-tag rec-
ognizing antibody M2.The Journal of Cell Biology, Volume 147, 1999 410
form was measured in the presence or absence of the in-
hibitory compound. In accordance with previously pub-
lished experimental data and recent structural evidence
(Kumar et al., 1997; Whitmarsh et al., 1997; Lisnock et al.,
1998) the inhibitor SB203580 had no effect on the g and d
isoforms of p38 (Fig. 7). Previously, SKF86002 has been
shown to inhibit p38a (Lee et al., 1994) and we show here
that it has no effect on the g and d isoforms. From these
results we can conclude that it is the p38a isoform that is
essential in the a2b1 integrin–dependent upregulation of
collagen.
Collagen Gel Induces Transient Activation of ERK1 
and 2 but not JNK/SAPK in Both the a2- and
a2/a1–Transfected Cells
We have recently shown that seeding dermal fibroblasts
inside three-dimensional collagen gels results in activa-
tion of ERK1 and 2, JNK/SAPK, and p38 MAPKs (Ra-
vanti et al., 1999). Therefore, we examined also the acti-
vation of ERK1 and 2 and JNK/SAPK in both a2- and a2/
a1–transfected Saos-2 cells by Western blot analysis of
cellular proteins, using phosphospecific antibodies to de-
tect activated forms of these MAP kinases. The levels of
activated ERK2 were increased 2 h after seeding the cells
inside collagen (3-fold in a2 and 1.5-fold in a2/a1 cells)
and they increased further (up to 4-fold in a2 and 7-fold
in a2/a1 cells) at 6 h time point. This activation in re-
sponse to the collagen gel was transient in both clones
since no phosphorylated ERK1 or 2 was detected at 12-h
time point. Protein levels of ERK2 remained constant at
all time points, as shown with the antibody recognizing all
forms of ERK2 (Fig. 8 A). Low levels of ERK1 were also
detected at 2-, 4-, and 6-h time points. No induction in the
levels of phosphorylated JNK/SAPK was seen in these
cells in response to three-dimensional collagen. Some ac-
tivated JNK/SAPK was seen at 0-h time point, immedi-
ately after trypsinization but no active protein was de-
tected inside collagen gel. Treatment with anisomycin was
used as a positive control for JNK activation. Protein lev-
els of JNK1 remained constant at all time points, as shown
with the antibody recognizing all forms of JNK1 (Fig. 8
B). The results with the phosphospecific antibodies were
confirmed with a JNK in vitro kinase assay. Endogenous
kinase was immunoprecipitated with anti–JNK1 antibody
recognizing also JNK2 and 3 and recombinant c-Jun pro-
tein was used as a substrate (Fig. 8 C).
Three-dimensional Collagenous Matrix Fails to 
Activate FAK
Ligation of integrins leads to activation of FAK. To check
whether FAK would play a role in the activation of p38 in
response to three-dimensional collagen, we allowed both
a2- and a2/a1–transfected cells to interact with collagen
gels for 1, 2, or 3 h. (Fig. 9 or not shown). The polymeriza-
tion of the collagen gel takes place in 1 h, so shorter time
points could not be studied. No phosphorylated FAK was
detected in cells treated with collagen, in contrast to cells
from both clones adhering to fibronectin (Fig. 9). Some
phosphorylation of FAK was seen in cells lyzed immedi-
ately after trypsinization. The experiment was repeated
with similar results by using antibodies recognizing all
phosphorylated forms of FAK (Fig. 9). In the lower panel
of Fig. 9 phosphorylated FAK is the upper band. The
lower band seen in all samples could not be recognized by
anti–FAK antibody and its identity is unknown.
Effect of Inhibitors of GTPases and MAPKKs on
a2b1-mediated Activation of p38a
To investigate possible downstream effectors of a2b1 inte-
grin in the activation of p38a, we used dominant negative
mutants of the Rho family GTPases and the p38 upstream
kinases, MKK3 and MKK4. The effector mutants or an
empty vector in control cells were cotransfected with the
flag-tagged p38a into the a2-expressing cells and, 36 h
after transfection, the cells were exposed to three-dimen-
sional collagen and an in vitro p38 kinase assay was per-
formed. Of the Rho family GTPases Cdc42 seemed essen-
tial for a2b1-mediated signaling since dominant negative
Cdc42 constantly resulted in an inhibition of p38a activity
(Fig. 10 B). Similar inhibition was not seen when the cells
were transfected with wild-type Cdc42, used as a control.
In three separate experiments, 4 mg/plate dominant nega-
tive Rac slightly decreased p38a activity (75 6 12% of
control) and mutant RhoA was only somewhat more ef-
fective (70 6 27% of control). The experiment was also re-
peated with higher plasmid concentration (8 mg/plate) and
p38a activity was unaltered in dominant negative Rac
transfected cells (116% of control). Mutant RhoA showed
some inhibition (66% of control). Again, dominant nega-
tive Cdc42 was the most efficient (17% of control). The
dominant negative forms of the MAPK kinases known to
function upstream of p38, namely MKK3 and MKK4, both
had an inhibitory effect. Dominant negative MKK3 inhib-
ited p38a activity by 90–91% and dominant negative
MKK4 by 76–90% (Fig. 10). These results indicate that the
activity of Cdc42 and the MAPK kinases MKK3 and
MKK4 are necessary for the a2b1 integrin-mediated p38a
activation.
Discussion
The integrins provide a physical linkage between the cy-
Figure 7. The effect of p38 inhibitors SB203580
and SKF86002 on the various p38 isoforms.
Equal numbers of stable transfected Saos-2 cells
were transiently transfected with flag-tagged p38
isoforms (a, b2, g, or d). 36 h after transfection,
the cells were detached from the plate and
seeded inside collagen gel. After 3 h of incuba-
tion, the cells were collected and lysed, and flag-tagged p38 was immunoprecipitated. Before adding the ATF-2 protein as a substrate to
the kinase reaction the inhibitors or DMSO (control) were added. Levels of phosphorylated ATF-2 are shown.Ivaska et al. a2b1 Integrin Activates p38a 411
toskeleton and ECM and they transduce signals initiated
by extracellular interactions. Since integrins have no in-
trinsic kinase activity they need to recruit other proteins,
i.e., kinases to trigger signaling (for reviews see Clark and
Brugge, 1995; Yamada and Miyamoto, 1995). A rapidly in-
creasing number of molecules has been shown to interact
with integrins (for review see Hemler, 1998). One obvious
site for interaction is the cytoplasmic domain of an inte-
grin subunit and several proteins binding specifically to ei-
ther the a or the b cytoplasmic tail have been identified.
Interactions mediated by the membrane spanning region
of integrins have also been shown (Lindberg et al., 1993;
Berditchevski et al., 1995, 1996; Wary et al., 1996). These in-
teractions may be used differentially by different integrins
establishing the bases for receptor-specific signal transduc-
tion.
Integrin a subunit–specific interactions with other cel-
lular proteins are of special interest because they may
explain the distinct signaling functions of integrin het-
erodimers sharing a common b1 subunit (Werb et al.,
1989). The two collagen receptors, a1b1 and a2b1 inte-
grins, have distinct effects on cellular signaling and gene
expression (Langholz et al., 1995; Riikonen et al., 1995a;
Ravanti et al., 1999). Here, the function of their a cyto-
plasmic domains was studied by swapping the a1 tail into
a2 and expressing the chimeric integrin in cells negative
for a2 integrin.
The swapping of the a1 and a2 subunit cytoplasmic do-
mains did not affect the localization to focal adhesions or
the ability to mediate cell adhesion to collagen. This is in
agreement with previously published data where the spe-
cific sequence of the a tail seemed less important than the
number of residues present. Four to seven residues after
the conserved GFFKR sequence were needed to be in-
cluded for optimal adhesive activity (Kassner et al., 1994).
Here, fast cell spreading and the ability to contract three-
dimensional collagen gels were impaired if the cells ex-
pressed chimeric a2/a1 instead of the a2 integrin. Previ-
ously, a2, a4, and a5 cytoplasmic tails have been shown to
be interchangeable with respect to their positive contri-
Figure 8. Regulation of ERK
and JNK MAPKs in response
to collagen gel. Cells from
two separate a2 or a2/a1 sin-
gle cell clones (45, 47 and 2,
12) were pooled together and
either lysed immediately (0 h
sample) or seeded in collagen
gel and incubated for differ-
ent periods of time, as indi-
cated. (A) The levels of acti-
vated ERK1 and 2 (ERK1-P
and ERK2-P) were deter-
mined by Western blot analy-
sis using a phosphospecific
antibody for ERK1 and 2 and
an antibody recognizing all
forms of ERK2 was used as a
control. The levels of acti-
vated ERK1 and 2 were
quantitated using an image
analyzer system and are shown relative to the levels of total ERK2 present in each sample. (B) The levels of activated JNK1 and 2 were
determined by Western blot analysis using a phosphospecific antibody for JNK1 and 2, and an antibody recognizing all forms of JNK1
was used as a control. The positive control treatment (1) was 10 min anisomycin (10 mg/ml). For the kinase assay, equal numbers of sta-
ble transfected Saos-2 cells (a2 or a2/a1) were either lysed immediately after trypsinization, treated with collagen for 3 h or anisomycin
(10 mg/ml) for 10 min, and the JNK kinase activity was assayed.
Figure 9. Three-dimensional collagenous matrix fails to activate
FAK in Saos-2 cells. Cells from two separate a2 or a2/a1 single
cell clones (45, 47 and 2, 12) were pooled together and either
lysed immediately (0 h sample), seeded in collagen gel, or al-
lowed to adhere to fibronectin for 1 h. FAK was immunoprecipi-
tated and immunoplotted with an antiphosphotyrosine antibody
(4G10). Alternatively, cell lysates were fractionated on SDS-
PAGE and immunoblotted with phosphospecific FAK antibody.
The blots were reprobed with anti–FAK antibody to show the
levels of FAK protein. Note that in the lower panel the anti-phos-
pho FAK antibody recognizes two bands, but it is the upper one
that comigrates with the band recognized with the anti–FAK an-
tibody. The origin of the lower band is unknown.The Journal of Cell Biology, Volume 147, 1999 412
butions towards cell adhesion (Kawaguchi and Hemler,
1993), while the ability to mediate collagen gel contraction
and cell migration is more restricted to a specific set of a
cytoplasmic tails (Chan et al., 1992). Collagen gel contrac-
tion assays are used to study cell–type I collagen interac-
tion. It is generally thought that the reorganization of col-
lagen fibrils, seen as contraction of floating collagen gels,
is dependent on the expression of a2b1 on the cell surface
(Klein et al., 1991; Schiro et al., 1991; Riikonen et al.,
1995b). However, there are more recent reports indicating
that a1b1 can have an essential role in the contraction pro-
cess, especially in smooth muscle cells and liver myofibro-
blasts (Gotwals et al., 1996; Racine-Samson et al., 1997),
suggesting that a1 cytoplasmic tail, unlike the ones of a4
and a5, could mediate the same interactions as the a2 tail.
In contrast to these reports, our results do not support the
idea that a1b1 or chimeric a2/a1b1 could mediate col-
lagen gel contraction. This is also the case with a1- and a2/
a1–transfected CHO cells (Ivaska, J., and J. Heino, un-
published results). One explanation could be that a1b1
needs an interaction with a certain cytoplasmic structure
to be able to mediate contraction, and that this component
is only present in a subset of cell types.
Synergy between integrin-mediated signaling and sig-
nals initiated by growth factors has been well established
(Schlaepfer et al., 1994; Miyamoto et al., 1995, 1996). Path-
ways first identified to be activated by mitogens, the MAP
kinase cascades, have now been shown to be activated by
integrin ligation (Chen et al., 1994; Morino et al., 1995;
MacKenna et al., 1998). Furthermore, integrin specificity
in MAP kinase activation has been established. A subset
of integrins, namely a1b1,  a5b1,  a6b4, and aVb3, has
been shown to activate the Ras-ERK pathway via recruit-
ment of the adaptor protein Shc (Wary et al., 1996; Gian-
cotti, 1997). Other integrins (a2b1, a3b1, and a6b1) were
unable to induce ERK activation in these studies (Wary et
al., 1996).
Given the difference between a1b1 and a2b1 integrins
in activation of Ras-ERK pathway it is not surprising that
ligation of these two receptors have different effects on
cellular gene expression. Both a1b1 and a2b1 have been
shown to regulate collagen mRNA levels in response to
contact with three-dimensional collagen. Integrin a1b1
can function as a negative regulator of collagen synthesis
(Langholz et al., 1995; Riikonen et al., 1995a; Gardner et al.,
1999; Ravanti et al., 1999), whereas overexpression of
a2b1 in osteosarcoma cells results in an upregulation of
collagen mRNA levels (Riikonen et al., 1995a). Integrin
a2b1 seems to be a positive regulator of MMP-1 and
MMP-13 (collagenase-3) expression as well. Further, sup-
porting the differential signaling by these two receptors,
a1b1 is not involved in MMP-1 upregulation and it seems
to be a less potent upregulator of MMP-13 than a2b1 (Ra-
vanti et al., 1999). Activation of Ras-Raf-ERK pathway by
a1b1 integrin may lead to reduced collagen synthesis since
Ras-Raf activation has been shown to downregulate type I
collagen gene expression (Davis et al., 1996). Signaling
through a2b1 is less well characterized than a1b1 signal-
ing. MMP-1 upregulation in fibroblasts cultured inside
three-dimensional collagen is mediated by PKC-z and
NFkB, but these pathways have not been directly con-
nected to a2b1 (Xu and Clark, 1997). Three-dimensional
collagen mediates PKC-z activation in 4 h in CHO cells
even though they lack collagen receptor integrins (Ivaska,
J., and J. Heino, unpublished results) proposing that the
PKC-z activation might at least partly be due to a change
in cell shape rather than active signaling through collagen
binding integrins.
Previously, it has been shown that cell contact with ei-
ther two- or three-dimensional collagen induces activation
of ERK1 and ERK2 (Roeckel and Krieg, 1994; Langholz
et al., 1997). We have recently shown the participation of
p38 MAPK pathway in induction of MMP-13 expression
in response to cell–collagen interaction (Ravanti et al.,
1999). Here, we provide several lines of evidence that inte-
grin a2b1 regulates collagen gene transcription by activat-
ing p38a in response to collagen, and that this signaling re-
quires the a2 cytoplasmic domain. First, expression of
wild-type  a2 chain in cells exposed to collagen leads to up-
regulation of collagen mRNA levels. Chimeric receptor in
Figure 10. A possible role for RhoA, Cdc42, MKK3, and MKK4
in integrin a2b1-mediated activation of p38a. Equal numbers of
stable a2-transfected Saos-2 cells were transiently cotransfected
with flag-tagged p38a (2 mg) and the dominant negative form of
the protein indicated (4 mg). The cells were treated and assayed
for p38 kinase activity. The possible effect of the cotransfected
plasmid on p38a-flag expression was checked with Western blot
analysis of the cell lysate using flag-tag recognizing antibody M2.
An autoradiogram of a representative experiment is shown. (B)
Various concentrations of dominant negative (DN) Cdc42 were
tested in cotransfections with 2 mg of p38a-flag. Each experiment
was repeated 2 to 4 times and mean values 6 SEM are shown.
Transfection of wild-type (wt) Cdc42 was used as a control.Ivaska et al. a2b1 Integrin Activates p38a 413
which the cytoplasmic domain of a2 is replaced with the
corresponding sequence in a1, is not able to upregulate
collagen synthesis in response to three-dimensional ma-
trix. Second, regulation of collagen gene transcription was
shown to require p38 MAPK activity based on the use of
two p38 kinase inhibitors, SB203580 and SKF86002. Third,
contact with three-dimensional collagen results in only a
transient activation of ERK1 and 2, no evident activation
of SAPK/JNK, but persistent activation of p38 kinase. Ac-
tivation of p38 MAPK requires intact a2 subunit since lev-
els of activated p38 were significantly lower in cells ex-
pressing chimeric a2/a1 receptor. Finally, using transient
transfections of flag-tagged isoforms of p38 and dominant
negative signaling proteins, we were able to show that a2
cytoplasmic domain specifically activates the a isoform
and has no effect on the p38b2 isoform. We also show that
the activity of Cdc42 and the MAPK kinases MKK3 and
MKK4 is necessary for the a2b1 integrin-mediated p38a
activation.
The data presented clearly show that the p38a isoform is
essential in the a2b1 integrin–dependent upregulation of
collagen expression. The facts to support this areas fol-
lows. First, the p38a isoform is activated in response to
collagen in the a2-transfected but not the a2/a1–trans-
fected cells. Second, the p38b2 isoform is not activated in
these cells. Third, even though p38g showed high activity
in both clones and p38d was more efficiently activated in
the a2-transfected cells, these isoforms cannot be respon-
sible for the upregulation of collagen gene expression
since the p38 inhibitors used have no effect on these ki-
nases (Fig. 7). Together, these findings demonstrate that
the cytoplasmic sequence of a2 integrin subunit regulates
the ability of a2b1 integrin to activate p38 kinase in an iso-
form-specific manner and suggest a novel signaling mecha-
nism for a2b1.
An issue that arises from the data is the mechanism by
which a2b1 integrin activates the p38 pathway. Integrins
are known to activate the Rho family of GTPases. Integrin
ligation to the ECM leads to the activation of Cdc42 that
subsequently activates Rac; Rho, on the other hand, has
been shown to be activated independently of Cdc42 by in-
tegrin ligation (Price et al., 1998). Of the GTPases Cdc42
has been shown to activate both the p38 and JNK path-
ways and Rac1 has been shown to activate p38 (Bagrodia
et al., 1995; Coso et al., 1995; Minden et al., 1995; S. Zhang
et al., 1995). Cdc42 and Rac1 have been shown to induce
integrin-mediated cell motility on collagen and invasive-
ness through collagen gels (Keely et al., 1997), suggesting a
role for these small GTPases in the inside-out signaling
regulating the function of the collagen binding integrins.
Here we identify Cdc42 to be important for a2b1-medi-
ated signaling and also show that the MAPK kinases
MKK3 and MKK4 may be involved.
The signaling molecules downstream of Cdc42 and up-
stream of the MAPK kinases remain to be clarified in fur-
ther studies. The various p38 isoforms seem to be differen-
tially activated by upstream MAPKKs: MKK3, MKK4,
and MKK6 (Cohen et al., 1997; Jiang et al., 1997), which in
turn are activated by MAPKKKs (Denhardt, 1996). MAP-
KKKs shown to be effective in the p38 pathway involve
ASK and TAK1 (transforming growth factor–activated ki-
nase) (Derijard et al., 1995; Yamaguchi et al., 1995; W.
Wang et al., 1997) but little is known about their upstream
effectors. PI-3K has been shown to function in integrin-
mediated cell migration and invasion and it may function
upstream of Rac1 and Cdc42 (Keely et al., 1997). In fact, a
lipid product of PI-3K has been shown to interact with
Rac1 (Missy et al., 1998). A recent study shows that Cdc42
controls integrin-dependent activation of Akt (Clark et
al., 1998), a kinase whose activity is regulated by PI-3K
(Bondeva et al., 1998). Very recently a mechanism was
suggested in which PI-3K activates NFkB (Beraud et al.,
1999), a transcription factor that has been shown to be ac-
tivated in fibroblasts in response to collagen gel (Xu and
Clark, 1997). In our experiments, the PI-3K inhibitor,
wortmannin, slightly reduced a2b1-mediated upregulation
of collagen a1(I) thereby leaving open the possibility that
PI-3K may be one of the upstream effectors of the signal-
ing pathway described here.
Other candidates for upstream effectors that could me-
diate a2b1-related activation of p38 include p21 activated
kinases (PAKs), the best characterized effectors of Cdc42
and ACKs (activated Cdc42-binding kinases) recently
shown to be activated by cell adhesion via integrin b1
(Yang et al., 1999). In a study published by Bourdoulous
et al. (1998), alteration in integrin occupancy by fibronec-
tin led to upregulation of ACK and p38 MAPK while a
concomitant inhibition of PAK and JNK/SAPK was seen.
This is interesting from the point of view of this discussion
since similar effects on the MAPKs were seen in the a2-
transfected Saos cells in response to collagen. In addition,
TAK1 might be an interesting candidate, since it is acti-
vated by TGF-b and has been shown to activate both
MKK3 and MKK6 (Yamaguchi et al., 1995; Enslen et al.,
1998). On the other hand, TGF-b has many effects on the
cell, one of them being the upregulation of collagen levels
(Massagué, 1990). How is integrin signaling then trans-
duced to these molecules, especially to Cdc42? One attrac-
tive model for a2b1 signaling would be the phosphoryla-
tion of the a2 cytoplasmic domain. Phosphorylation in
response to integrin ligation could generate a binding site
for an effector kinase inside the cell. However, our prelim-
inary data have failed to convincingly show a2 phosphory-
lation in response to binding to collagen (Ivaska, J., and J.
Heino, unpublished results).
It is evident that the two collagen receptors studied here
function in close collaboration to regulate cell behavior in
response to collagenous matrix. Impaired regulation of
collagen turnover may lead to pathological conditions. For
example, skin fibroblasts from scleroderma patients show
upregulated collagen synthesis and concomitantly reduced
expression of a1b1 (Ivarsson et al., 1993). A striking ex-
ample of correlated functions of integrins a1b1 and a2b1
is seen in a1 null mice, in which the absence of a1b1 leads
to enhanced collagen synthesis in skin. However, simulta-
neously collagenase-3 expression is increased, possibly via
increased a2b1 ligation, leading to a situation in which the
collagen accumulation is seen only if the degradation of
collagen is prevented (Gardner et al., 1999). Previous stud-
ies have shown the regulation of specific MAPK pathways
by a1b1 integrin (Wary et al., 1996) and also introduced
the dual role of MAPK pathways in the regulation of col-
lagen production (Davis et al., 1996). Here, we provide
new information which connects a2b1 integrin to the regu-The Journal of Cell Biology, Volume 147, 1999 414
lation of p38a via Cdc42 and MAPKKs, MKK3 and
MKK4, and show how a2b1 functions in the regulation of
the delicate balance of collagen accumulation in tissues.
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